SMMT:Summit Therapeutics Inc - Stock Price Quote and Dividend Data
SMMT STOCK PRICE LATEST CLOSE
$16.64
EXCHANGE
NASDAQ
SECTOR / SEGMENT / INDUSTRY
Health Care / Pharmaceuticals & Biotechnology / Biotechnology
Summit Therapeutics Inc Dividend Information
Trailing 12 Month Dividend YieldN/A
Projected 10 Year Dividend Yield0.00%
Dividend Yield 5 Year Average0.00%
Dividend Rate (IAD)$0.00
Dividend Payout Ratio0.00%
Dividend Payout Ratio 5 yr Average0.00%
Dividend Growth Rate 3 yr Average0.00%
Dividend Growth Rate 5 yr Average0.00%
Dividend AllStar™ Ranking
Consecutive Dividend Increases0 Years
Dividend Declaration DateNone
Dividend Ex DateNone
Dividend Record DateNone
Dividend Pay DateNone
Dividend Amount Current$0.000
Dividend Amount Previous$0.000
Dividends Paid in the Last 12 Months0
First Dividend Paid1970
Summit Therapeutics Inc Stock Price Information
52-Week Low/High Stock Price$2.10 - $33.89
Percent Held by Institutions10.05%
Revenue$0
Net Income$-282,518,000
Cash Flow$-190,779,000
EPS-0.09%
Market Cap$12,274,995,200
PE Ratio to Industry40%
Debt-Equity Ratio0.00%
Debt-Equity to Industry1.42%
Total Return Last 12 Months321.27%
Total Return Last 3 Years652.94%
Total Return Last 5 Years547.47%
Latest Trade DateApr. 08, 2025
Summit Therapeutics Inc Annual Stock Dividends
No Data available for Payment History.
Summit Therapeutics Inc Dividend Payment History
| No dividends retrieved for SMMT |
Summit Therapeutics Inc Other Dividend Details
Summit Therapeutics is holding company. Through its subsidiaries, Co. is a biopharmaceutical company focused on the discovery, development, and commercialization of medicinal therapies. Co.'s ivonescimab is a bispecific antibody that combines the benefits of immunotherapy via a blockade of PD-1 with the anti-angiogenesis benefits of an anti-vascular endothelial growth factor into a single molecule. Co. also focuses on ridinilazole, its product candidate for treating patients suffering from Clostridioides difficile infection. Co.'s other product candidate, SMT-738, is in development for combating multidrug resistant infections, specifically carbapenem-resistant Enterobacteriaceae infections.
SectorHealth Care
SegmentPharmaceuticals & Biotechnology
IndustryBiotechnology
Dividend AllStar™ Ranking
Re-Investment AgentNone
Direct Purchase Minimum$0
Optional Cash Pay Min-Max$0 - $0
Optional Cash Payment FrequencyNone
Mar. 01, 2025SMMT STOCK PRICE INCREASE: Summit Therapeutics Inc on 03-01-2025 increased stock price > 10% from $18.49 to $20.69
Feb. 25, 2025SMMT STOCK PRICE DECREASE: Summit Therapeutics Inc on 02-25-2025 decreased stock price > 10% from $22.12 to $18.84
Feb. 14, 2025SMMT STOCK PRICE INCREASE: Summit Therapeutics Inc on 02-14-2025 increased stock price > 10% from $19.57 to $21.82
Jan. 22, 2025SMMT STOCK PRICE INCREASE: Summit Therapeutics Inc on 01-22-2025 increased stock price > 10% from $19.03 to $22.10
Oct. 31, 2024SMMT STOCK PRICE DECREASE: Summit Therapeutics Inc on 10-31-2024 decreased stock price > 10% from $21.83 to $18.65
Sep. 24, 2024SMMT STOCK PRICE DECREASE: Summit Therapeutics Inc on 09-24-2024 decreased stock price > 10% from $24.39 to $21.91
Sep. 18, 2024SMMT STOCK PRICE DECREASE: Summit Therapeutics Inc on 09-18-2024 decreased stock price > 10% from $29.48 to $26.22
Sep. 14, 2024SMMT STOCK PRICE INCREASE: Summit Therapeutics Inc on 09-14-2024 increased stock price > 10% from $27.41 to $31.93
Sep. 13, 2024SMMT STOCK PRICE INCREASE: Summit Therapeutics Inc on 09-13-2024 increased stock price > 10% from $22.70 to $27.41
Sep. 11, 2024SMMT STOCK PRICE INCREASE: Summit Therapeutics Inc on 09-11-2024 increased stock price > 10% from $19.14 to $22.97
Apr. 09, 2025TCBPY STOCK PRICE DECREASE: TC BioPharm (Holdings) plc on 04-09-2025 decreased stock price > 10% from $0.40 to $0.27
Apr. 09, 2025MAZE STOCK PRICE DECREASE: Maze Therapeutics Inc on 04-09-2025 decreased stock price > 10% from $8.92 to $7.57
Apr. 09, 2025KANT STOCK PRICE DECREASE: Kineta Inc on 04-09-2025 decreased stock price > 10% from $0.35 to $0.30
Apr. 09, 2025ORKA STOCK PRICE DECREASE: Oruka Therapeutics Inc on 04-09-2025 decreased stock price > 10% from $7.62 to $6.78
Apr. 09, 2025XCUR STOCK PRICE DECREASE: Com Par $0.0001/Exicure Inc on 04-09-2025 decreased stock price > 10% from $12.80 to $11.39
Apr. 09, 2025BIVI STOCK PRICE DECREASE: Cl A Par $0.0001/BioVie Inc on 04-09-2025 decreased stock price > 10% from $0.80 to $0.71
Apr. 09, 2025ARTV STOCK PRICE DECREASE: Artiva Biotherapeutics Inc on 04-09-2025 decreased stock price > 10% from $3.31 to $1.92
Apr. 09, 2025ENTO STOCK PRICE DECREASE: Com Par $0.0001 (New)/Entero Therapeutics Inc on 04-09-2025 decreased stock price > 10% from $0.49 to $0.42
Apr. 09, 2025APDN STOCK PRICE DECREASE: Com Par $0.001 (New)/Applied DNA Sciences Inc on 04-09-2025 decreased stock price > 10% from $1.30 to $1.13
Apr. 09, 2025RKVTF STOCK PRICE DECREASE: Rakovina Therapeutics Inc on 04-09-2025 decreased stock price > 10% from $0.06 to $0.05
